Diverse Conjunctival Adverse Events Associated with Tisotumab Vedotin2026-07-060 PRE AI IIsana Nakajima KKen Fukuda KKenji Yamashiro DOI:10.1016/j.ophtha.2026.06.009OriginalOriginal request for helpShareSaveAbstract En